» Articles » PMID: 36815295

Putting Novel Ablation Technologies to the Test

Overview
Authors
Affiliations
Soon will be listed here.
References
1.
Althoff T, Mont L . Novel concepts in atrial fibrillation ablation-breaking the trade-off between efficacy and safety. J Arrhythm. 2021; 37(4):904-911. PMC: 8339092. DOI: 10.1002/joa3.12592. View

2.
Althoff T, Garre P, Caixal G, Perea R, Prat S, Tolosana J . Late gadolinium enhancement-MRI determines definite lesion formation most accurately at 3 months post ablation compared to later time points. Pacing Clin Electrophysiol. 2021; 45(1):72-82. DOI: 10.1111/pace.14415. View

3.
Mont L, Roca-Luque I, Althoff T . Ablation Lesion Assessment with MRI. Arrhythm Electrophysiol Rev. 2022; 11:e02. PMC: 9014705. DOI: 10.15420/aer.2021.63. View

4.
Leshem E, Zilberman I, Tschabrunn C, Barkagan M, Contreras-Valdes F, Govari A . High-Power and Short-Duration Ablation for Pulmonary Vein Isolation: Biophysical Characterization. JACC Clin Electrophysiol. 2018; 4(4):467-479. DOI: 10.1016/j.jacep.2017.11.018. View

5.
Caixal G, Alarcon F, Althoff T, Nunez-Garcia M, Benito E, Borras R . Accuracy of left atrial fibrosis detection with cardiac magnetic resonance: correlation of late gadolinium enhancement with endocardial voltage and conduction velocity. Europace. 2020; 23(3):380-388. DOI: 10.1093/europace/euaa313. View